These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 30312482

  • 1. The efficacy of extracorporeal photopheresis to arrest bronchiolitis obliterans in lung allograft recipients was compared between two automated photopheresis instruments.
    Chionis L, Grossman BJ, Hachem R, Commean P, Derfler MC, Vedantham S, Dodds K, Spitznagel E, Atkinson J, Despotis G.
    Transfusion; 2018 Dec; 58(12):2933-2941. PubMed ID: 30312482
    [Abstract] [Full Text] [Related]

  • 2. Development of iron deficiency anemia in patients undergoing extracorporeal photopheresis: Comparison of the UVAR and CELLEX instruments.
    Moosavi MM, Goodman AL, Duncan A, Stowell SR, Waller EK, Roback JD, Sullivan HC.
    J Clin Apher; 2021 Feb; 36(1):34-40. PubMed ID: 32894888
    [Abstract] [Full Text] [Related]

  • 3. Linear relationship between lymphocyte counts in peripheral blood and buffy coat collected during extracorporeal photopheresis.
    Liu C, Shah K, Dynis M, Eby CS, Grossman BJ.
    Transfusion; 2013 Nov; 53(11):2635-43. PubMed ID: 23414109
    [Abstract] [Full Text] [Related]

  • 4. Extracorporeal photopheresis performed on the CELLEX® compared with the UVAR-XTS® instrument is more efficient and better tolerated in children with steroid-refractory graft-versus-host disease.
    Kapadia E, Wong E, Perez-Albuerne E, Jacobsohn D.
    Pediatr Blood Cancer; 2015 Aug; 62(8):1485-8. PubMed ID: 25881179
    [Abstract] [Full Text] [Related]

  • 5. The CELLEX is comparable to the UVAR-XTS for the treatment of acute and chronic graft versus host disease (GVHD).
    Afzal A, Tarbunova M, Despotis G, Grossman BJ.
    Transfusion; 2020 Feb; 60(2):351-357. PubMed ID: 31919871
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparison of the CELLEX™ and UVAR-XTS™ closed-system extracorporeal photopheresis devices in the treatment of chronic graft-versus-host disease.
    Whittle RM, Denney H, Chantry AD, Alfred A, Taylor PC.
    J Clin Apher; 2017 Dec; 32(6):462-473. PubMed ID: 28608529
    [Abstract] [Full Text] [Related]

  • 8. Extracorporeal photopheresis to attenuate decline in lung function due to refractory obstructive allograft dysfunction.
    EPI Study Group, Hage CA, Klesney-Tait J, Wille K, Arcasoy S, Yung G, Hertz M, Chan KM, Morrell M, Goldberg H, Vedantham S, Derfler MC, Commean P, Berman K, Spitznagel E, Atkinson J, Despotis G.
    Transfus Med; 2021 Aug; 31(4):292-302. PubMed ID: 33955079
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Lung transplant recipients on long-term extracorporeal photopheresis.
    Isenring B, Robinson C, Buergi U, Schuurmans MM, Kohler M, Huber LC, Benden C.
    Clin Transplant; 2017 Oct; 31(10):. PubMed ID: 28653398
    [Abstract] [Full Text] [Related]

  • 11. Extracorporeal photopheresis after lung transplantation: a 10-year single-center experience.
    Benden C, Speich R, Hofbauer GF, Irani S, Eich-Wanger C, Russi EW, Weder W, Boehler A.
    Transplantation; 2008 Dec 15; 86(11):1625-7. PubMed ID: 19077900
    [Abstract] [Full Text] [Related]

  • 12. Cessation of extracorporeal photopheresis in chronic lung allograft dysfunction: effects on clinical outcome in adults.
    Robinson CA, Huber L, Murer C, Schuurmans M, Kohler M, Hofbauer G, Benden C.
    Swiss Med Wkly; 2017 Dec 15; 147():w14429. PubMed ID: 28488260
    [Abstract] [Full Text] [Related]

  • 13. A prospective interventional study on the use of extracorporeal photopheresis in patients with bronchiolitis obliterans syndrome after lung transplantation.
    Jaksch P, Scheed A, Keplinger M, Ernst MB, Dani T, Just U, Nahavandi H, Klepetko W, Knobler R.
    J Heart Lung Transplant; 2012 Sep 15; 31(9):950-7. PubMed ID: 22884382
    [Abstract] [Full Text] [Related]

  • 14. The efficacy of photopheresis for bronchiolitis obliterans syndrome after lung transplantation.
    Morrell MR, Despotis GJ, Lublin DM, Patterson GA, Trulock EP, Hachem RR.
    J Heart Lung Transplant; 2010 Apr 15; 29(4):424-31. PubMed ID: 19853479
    [Abstract] [Full Text] [Related]

  • 15. Therapy options for chronic lung allograft dysfunction-bronchiolitis obliterans syndrome following first-line immunosuppressive strategies: A systematic review.
    Benden C, Haughton M, Leonard S, Huber LC.
    J Heart Lung Transplant; 2017 Sep 15; 36(9):921-933. PubMed ID: 28662986
    [Abstract] [Full Text] [Related]

  • 16. Long-Term Off-Line Extracorporeal Photochemotherapy in Patients with Chronic Lung Allograft Rejection Not Responsive to Conventional Treatment: A 10-Year Single-Centre Analysis.
    Del Fante C, Scudeller L, Oggionni T, Viarengo G, Cemmi F, Morosini M, Cascina A, Meloni F, Perotti C.
    Respiration; 2015 Sep 15; 90(2):118-28. PubMed ID: 26112178
    [Abstract] [Full Text] [Related]

  • 17. Early extracorporeal photopheresis treatment is associated with better survival in patients with chronic or recurrent acute lung allograft dysfunction.
    Gautschi F, Vogelmann T, Ortmanns G, Knörr F, Steinack C, Hage R, Nägeli M, Schuurmans MM.
    J Clin Apher; 2024 Jun 15; 39(3):e22128. PubMed ID: 38829041
    [Abstract] [Full Text] [Related]

  • 18. Extracorporeal Photopheresis Improves Survival in Hematopoietic Cell Transplant Patients with Bronchiolitis Obliterans Syndrome without Significantly Impacting Measured Pulmonary Functions.
    Hefazi M, Langer KJ, Khera N, Adamski J, Roy V, Winters JL, Gastineau DA, Jacob EK, Kreuter JD, Gandhi MJ, Hogan WJ, Litzow MR, Hashmi SK, Yadav H, Iyer VN, Scott JP, Wylam ME, Cartin-Ceba R, Patnaik MM.
    Biol Blood Marrow Transplant; 2018 Sep 15; 24(9):1906-1913. PubMed ID: 29679771
    [Abstract] [Full Text] [Related]

  • 19. CD209+ monocyte-derived myeloid dendritic cells were increased in patients with leukemic cutaneous T-cell lymphoma undergoing extracorporeal photopheresis via the CELLEXTM system.
    Ni X, Austin M, Langridge T, Bojaxhi P, Bijani P, Wang X, Duvic M.
    Photodermatol Photoimmunol Photomed; 2020 Jul 15; 36(4):290-298. PubMed ID: 32187738
    [Abstract] [Full Text] [Related]

  • 20. Effect of extracorporeal photopheresis on lung function decline for severe bronchiolitis obliterans syndrome following allogeneic stem cell transplantation.
    Brownback KR, Simpson SQ, Pitts LR, Polineni D, McGuirk JP, Ganguly S, Aljitawi OS, Lin TL, Singh A, Abhyankar S.
    J Clin Apher; 2016 Aug 15; 31(4):347-52. PubMed ID: 26031713
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.